Accelerating GMP Tech Transfer: Translating Novel Radiopharmaceutical Platforms from Discovery to First-in- Human

11:30 am - Thursday 3rd December 2026

  • Preparing novel radiopharmaceutical technologies for successful GMP tech transfer and clinical manufacturing
  • Lessons learned navigating analytical, CMC and operational challenges during technology transfer
  • Coordinating discovery, manufacturing and clinical teams to enable seamless progression into Phase I
  • Key considerations for de-risking technology transfer while maintaining programme momentum

Speakers:

Chief Technology Officer
Nuclide Therapeutics